These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18404788)

  • 1. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
    Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
    J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the Z protein protease inhibitor and risk of venous thromboembolism: a meta-analysis.
    Dentali F; Gianni M; Lussana F; Squizzato A; Cattaneo M; Ageno W
    Br J Haematol; 2008 Oct; 143(2):284-7. PubMed ID: 18710385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].
    Schramm W; Heinemann LA; Spannagl M; Dick A; Assmann A
    Dtsch Med Wochenschr; 2000 Jan; 125(1-2):2-6. PubMed ID: 10650817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.
    Baba-Ahmed M; Le Gal G; Couturaud F; Lacut K; Oger E; Leroyer C
    Thromb Haemost; 2007 Feb; 97(2):171-5. PubMed ID: 17264942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Aalpha-Thr312Ala and factor XIII-A Val34Leu polymorphisms in idiopathic venous thromboembolism.
    Le Gal G; Delahousse B; Lacut K; Malaviolle V; Regina S; Blouch MT; Couturaud F; Mottier D; Oger E; Gruel Y;
    Thromb Res; 2007; 121(3):333-8. PubMed ID: 17568659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis.
    Dentali F; Galli M; Gianni M; Ageno W
    Thromb Haemost; 2008 Apr; 99(4):675-82. PubMed ID: 18392325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.
    Kennedy M; Andreescu AC; Greenblatt MS; Jiang H; Thomas CA; Chassereau L; Wong C; Durda P; Cushman M
    Br J Haematol; 2005 Feb; 128(3):386-8. PubMed ID: 15667542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.
    Rehak M; Rehak J; Müller M; Faude S; Faude F; Siegemund A; Krcova V; Slavik L; Hasenclever D; Scholz M; Wiedemann P
    Thromb Haemost; 2008 May; 99(5):925-9. PubMed ID: 18449423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
    Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
    Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The related analysis of venous thromboembolism and cSNPs of coagulation factor V gene].
    Wei XQ; Dai J; Han XM; Ren JF; Yang XL; Jin PP; Ding QL; Wang XF; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):165-8. PubMed ID: 17649708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden.
    Lincz LF; Lonergan A; Scorgie FE; Rowlings P; Gibson R; Lawrie A; Seldon M
    Pathophysiol Haemost Thromb; 2006; 35(6):435-9. PubMed ID: 17565236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
    Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
    Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.